WHO plan on fake medicines could signal retreat from IMPACT
This article was originally published in SRA
Executive Summary
In a move that could herald a reduction in the World Health Organization's controversial involvement in the IMPACT anti-counterfeiting initiative, the body is to set up a new, member state-run mechanism to tackle the problem of substandard, falsified and counterfeit medicines1.